RBC Capital raised the firm’s price target on Azek (AZEK) to $50 from $46 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company’s higher-end mix, market share gains, and new products continue to provide resilience against broader market weakness, with recent re-acceleration in sell-through seen as “encouraging” and suggesting potential upside to the management’s Q1 guide, the analyst tells investors in a research note.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter